Chemical Communications 2011-02-14

A cross-over inhibitor of the botulinum neurotoxin light chain B: a natural product implicating an exosite mechanism of action.

Nicholas T Salzameda, Lisa M Eubanks, Joseph S Zakhari, Kyoji Tsuchikama, Nicholas J DeNunzio, Karen N Allen, Mark S Hixon, Kim D Janda

Index: Chem. Commun. (Camb.) 47(6) , 1713-5, (2011)

Full Text: HTML

Abstract

Clostridium botulinum produces the most lethal toxins known to man, as such they are high risk terrorist threats, and alarmingly there is no approved therapeutic. We report the first cross-over small molecule inhibitor of these neurotoxins and propose a mechanism by which it may impart its inhibitory activity.

Related Compounds

Related Articles:

[Simultaneous determination of five organic acids in Kudiezi injection by HPLC].

2013-10-01

[Zhongguo Zhong Yao Za Zhi 38(19) , 3287-90, (2013)]

Application of an online post-column derivatization HPLC-DPPH assay to detect compounds responsible for antioxidant activity in Sonchus oleraceus L. leaf extracts.

2013-02-01

[J. Pharm. Pharmacol. 65(2) , 271-9, (2013)]

Echinacea alkylamides modulate induced immune responses in T-cells.

2008-01-01

[Fitoterapia 79(1) , 53-8, (2008)]

Large-scale cultivation of adventitious roots of Echinacea purpurea in airlift bioreactors for the production of chichoric acid, chlorogenic acid and caftaric acid.

2007-08-01

[Biotechnol. Lett. 29(8) , 1179-82, (2007)]

Augmentation of immune response by chicoric acid through the modulation of CD28/CTLA-4 and Th1 pathway in chronically stressed mice.

2011-05-01

[Neuropharmacology 60(6) , 852-60, (2011)]

More Articles...